Job Watch

Findings of Research Misconduct

Notice NOT-OD-20-154 from the NIH Guide for Grants and Contracts

Hyper Recruitment Solutions (HRS): NGS Team Leader

New Scientist - Bioinformatics - Wed, 2020-07-29 06:07
Competitive: Hyper Recruitment Solutions (HRS): We are currently looking for an NGS Team Leader to join an exciting Genomics CRO, as they build their new NGS team in Cambridge. As... Cambridgeshire
Categories: Job Watch

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

Funding Opportunity PAR-20-285 from the NIH Guide for Grants and Contracts. This FOA encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately preparatory to trials in stroke prevention, treatment, and recovery; and ancillary studies designed to add scientific aims to active studies being conducted within StrokeNet. Successful applicants will collaborate and conduct the study within the NIH StrokeNet. Following peer review, NINDS will prioritize studies among the highest scoring to be conducted in the NIH StrokeNet infrastructure. The NIH StrokeNet National Coordinating Center (NCC) will work with the successful applicant to implement the proposed study efficiently and the National Data Management Center (NDMC) will provide statistical and data management support. The NIH StrokeNet Regional Coordinating Centers (RCCs) and their affiliated clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol.

Hyper Recruitment Solutions (HRS): NGS Scientist

New Scientist - Bioinformatics - Tue, 2020-07-28 13:39
Competitive: Hyper Recruitment Solutions (HRS): We are currently looking for an NGS Scientist to join an exciting Genomics CRO, as they build their new NGS team in Cambridge. As the /... Cambridgeshire
Categories: Job Watch

The NINDS Human Biospecimen and Data Repository (U24 Clinical Trial Not Allowed)

Funding Opportunity RFA-NS-20-031 from the NIH Guide for Grants and Contracts. The National Institute of Neurological Disorders and Stroke (NINDS) is soliciting applications for a Human Biospecimen and Data Repository for Biomarkers Research ("Biomarkers Repository") in Neurological Disorders. Collaborative teams combining expertise in neuroscience, biomarkers, biospecimen handling, and data management are encouraged. Experience in biomarker research, such as evaluation of batch effects, protocol development, and analyte quality control measures, is expected. Successful applications will include a detailed description of 1) Administrative Structure, 2) Research and Resource Plan, and 3) Data Management and Web-Based activities.

Policy Update - Results Information Reporting for Applicable Clinical Trials (ACTs)

Notice NOT-OD-20-147 from the NIH Guide for Grants and Contracts

Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)

Funding Opportunity PAR-20-254 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional)

Funding Opportunity PAR-20-255 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.

Pages

Subscribe to Anil Jegga aggregator - Job Watch